Page last updated: 2024-10-28

guanfacine and Coronary Disease

guanfacine has been researched along with Coronary Disease in 2 studies

Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Widimský, J1
Bazika, V1
Neuzil, P1
Tiserová, J1
Hrabovský, F1

Reviews

1 review available for guanfacine and Coronary Disease

ArticleYear
Antihypertensive treatment in mild hypertension, its problems and future trends.
    Cor et vasa, 1987, Volume: 29, Issue:4 Suppl 1

    Topics: Antihypertensive Agents; Blood Pressure; Coronary Disease; Forecasting; Guanfacine; Guanidines; Huma

1987

Other Studies

1 other study available for guanfacine and Coronary Disease

ArticleYear
[Improvement of the functional capacity of hypertensive patients treated with guanfacine].
    Casopis lekaru ceskych, 1986, May-23, Volume: 125, Issue:21

    Topics: Adult; Antihypertensive Agents; Blood Pressure; Coronary Disease; Follow-Up Studies; Guanfacine; Gua

1986